Copernicus Receives $1M from Cystic Fibrosis Foundation Therapeutics To Advance Development of a Non-Viral Gene Therapy for Cystic Fibrosis.
Business Wire › January 20, 2005
Linked as:
Extract
Copernicus Receives $1M from Cystic Fibrosis Foundation Therapeutics To Advance Development of a Non-Viral Gene Therapy for Cystic Fibrosis.
CLEVELAND -- Copernicus Therapeutics, Inc. today announced that it has received an extension to its therapeutics development award from Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT). This award in the amount of $750,000 was coupled with a $280,000 outstanding payment from the ori...
See the full content of this document
Sponsored links
